SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Su Wei-guo

(Last)

(First)

(Middle)

C/O 48TH FLOOR, CHEUNG KONG CENTER, 2

QUEEN'S ROAD CENTRAL

(Street)

HONG KONG

00000

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
HUTCHMED (China) Ltd [ HCM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and CSO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
ordinary shares	3,563,905	D
American depositary shares⁽¹⁾	237,063	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share option (right to buy)⁽²⁾	03/27/2017	03/26/2027	ordinary shares	1,000,000	⁽³⁾	D
Share option (right to buy)⁽²⁾	03/19/2018	03/18/2028	ordinary shares	1,000,000	⁽⁴⁾	D
Share option (right to buy)⁽²⁾	04/28/2020	04/27/2030	American depositary shares	157,940	$22.09⁽⁵⁾	D
Share option (right to buy)⁽²⁾	12/14/2020	12/13/2030	American depositary shares	3,792	$29⁽⁵⁾	D
Share option (right to buy)⁽²⁾	03/26/2021	03/25/2031	American depositary shares	56,480	$27.94⁽⁵⁾	D
Share option (right to buy)⁽²⁾	12/14/2021	12/13/2031	American depositary shares	4,986	$35.21⁽⁵⁾	D
Share option (right to buy)⁽⁶⁾	08/05/2024	08/04/2034	ordinary shares	1,405,767	⁽⁷⁾	D
Share option (right to buy)⁽⁶⁾	06/09/2025	06/08/2035	ordinary shares	1,493,435	⁽⁸⁾	D
Long Term Incentive Plan awards granted on 03/13/2024	⁽⁹⁾	⁽⁹⁾	ordinary shares	39,862	⁽⁹⁾	I	Held by Long Term Incentive Plan trustee
Long Term Incentive Plan awards granted on 08/05/2024	⁽¹⁰⁾	⁽¹⁰⁾	ordinary shares	169,977	⁽¹⁰⁾	I	Held by Long Term Incentive Plan trustee

Explanation of Responses:

1. Each American depositary share represents 5 ordinary shares.

2. The share options granted are exercisable subject to, amongst other relevant vesting criteria, the vesting schedule of 25% on each of the first, second, third and fourth anniversaries of the date of grant of share options.

3. The exercise price for the share option is GBP3.105 per ordinary share.

4. The exercise price for the share option is GBP4.974 per ordinary share.

5. The exercise price for the share option is denominated in United States dollar per American depositary share.

6. The exercise of the share options granted is conditional upon the fulfilment of performance targets prescribed by the Board for the relevant performance periods (2023-2025, 2024-2026 and 2025-2027), as set out in the respective grant letters. For each grant, the number of share options that may become exercisable will be determined on the date of announcement of the annal results of the Company for the final financial year of the applicable performance period (i.e. the annual results announcements for the financial years ending December 31, 2025, 2026 and 2027, respectively). Vesting will occur two business days after the relevant results announcement. Any share options in respect of which the applicable performance targets are not met will lapse accordingly.

7. The exercise price for the share option is HKD29.200 per ordinary share.

8. The exercise price for the share option is HKD25.500 per ordinary share.

9. 25% of Long Term Incentive Plan Awards vesting on each of March 13, 2025, March 13, 2026, March 13, 2027 and March 13, 2028.

10. All Long Term Incentive Plan Awards will vest in 2027, three weeks after the date of completion of the share purchase for the awards for the financial year ending December 31, 2026.

	/s/ Su Wei-guo	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.